Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Onset of Iron Overload Cardiomyopathy in Cirrhosis.

JACC. Case reports·2026
Same author

Comparison of the Association of Area-Based Deprivation Indices With Hypertension and Diabetes Control Outcomes.

Journal of the American Heart Association·2026
Same author

Multimorbidity in Atrial Fibrillation: Impact on Outcomes.

Journal of the American Heart Association·2026
Same author

Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance.

JACC. Heart failure·2026
Same author

Burden of Potentially Undiagnosed Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation and Effects of Catheter Ablation: Insights From CABANA.

Journal of the American Heart Association·2026
Same author

Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.

Circulation·2026

Related Experiment Videos

Anemia and heart failure: a community study.

Shannon M Dunlay1, Susan A Weston, Margaret M Redfield

  • 1Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

The American Journal of Medicine
|August 12, 2008
PubMed
Summary

Anemia affects half of heart failure patients, with prevalence increasing over time. This condition, particularly in preserved ejection fraction heart failure, significantly raises mortality risk.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Hematology
  • Epidemiology

Background:

  • Anemia is a significant comorbidity in heart failure (HF), linked to increased mortality.
  • Understanding anemia prevalence and its impact is crucial for HF management.

Purpose of the Study:

  • To determine the prevalence of anemia in a community HF population.
  • To analyze trends in anemia prevalence over time.
  • To evaluate the role of anemia in HF with preserved ejection fraction (HFpEF) versus HF with reduced ejection fraction (HFrEF).

Main Methods:

  • Retrospective (1979-2002, n=1063) and prospective (2003-2006, n=677) cohorts of Olmsted County residents with HF were analyzed.
  • Clinical characteristics were collected, and anemia was defined using World Health Organization criteria.

Main Results:

  • Anemia prevalence was 40% in the retrospective cohort and 53% in the prospective cohort.
  • Anemia prevalence increased by 16% from 1979-2002 and was higher in HFpEF (58%) versus HFrEF (48%).
  • Anemia significantly increased mortality risk (P<.001), with a J-shaped relationship between hemoglobin levels and mortality.

Conclusions:

  • Approximately half of community heart failure patients are anemic, with rising prevalence.
  • Anemia is more common in HFpEF and is a strong predictor of increased mortality in HF patients.